MedTrace Logo

Zimmer Biomet Shoulder Arthroplasty PMCF Study

NCT06920459 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2025-12-08

No results posted yet for this study

Summary

This is a multicenter, prospective, non-controlled post market surveillance study. The objectives of this study are to confirm the safety, performance, and clinical benefits of the Zimmer Biomet Shoulder Arthroplasty systems in primary anatomic shoulder arthroplasty and its instrumentation. Safety of the systems will be assessed by monitoring the frequency and incidence of adverse events. The performance and clinical benefits will be evaluated by assessment of the overall pain and functional performance, qualify of life, and radiographic parameters of all enrolled study subjects.

Conditions

  • Shoulder Fractures
  • Shoulder Arthritis Osteoarthritis
  • Shoulder Injury
  • Shoulder Pain
  • Degenerative Joint Disease
  • Arthritis Shoulder

Interventions

DEVICE

Alliance™ Glenoid

Total Shoulder Arthroplasty using the Alliance™ Glenoid implant

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Emilie Rohmer · Zimmer Biomet

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-29
Primary Completion
2028-12-31
Completion
2036-12-31

Countries

  • Germany
  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06920459 on ClinicalTrials.gov